Kurs
+1,97%
Likviditet
219 MSEK
Kalender
Est. tid* | ||
2025-11-07 | 07:50 | Kvartalsrapport 2025-Q3 |
2025-08-08 | 07:50 | Kvartalsrapport 2025-Q2 |
2025-05-23 | N/A | X-dag ordinarie utdelning RAY B 3.00 SEK |
2025-05-22 | N/A | Årsstämma |
2025-05-09 | 07:50 | Kvartalsrapport 2025-Q1 |
2025-02-21 | - | Bokslutskommuniké 2024 |
2024-11-08 | - | Kvartalsrapport 2024-Q3 |
2024-08-16 | - | Kvartalsrapport 2024-Q2 |
2024-05-23 | - | X-dag bonusutdelning RAY B 1.3 |
2024-05-23 | - | X-dag ordinarie utdelning RAY B 0.70 SEK |
2024-05-22 | - | Årsstämma |
2024-05-17 | - | Kvartalsrapport 2024-Q1 |
2024-02-23 | - | Bokslutskommuniké 2023 |
2023-11-17 | - | Kvartalsrapport 2023-Q3 |
2023-08-25 | - | Kvartalsrapport 2023-Q2 |
2023-05-26 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
2023-05-25 | - | Årsstämma |
2023-05-17 | - | Kvartalsrapport 2023-Q1 |
2023-02-28 | - | Bokslutskommuniké 2022 |
2022-11-29 | - | Kvartalsrapport 2022-Q3 |
2022-08-29 | - | Kvartalsrapport 2022-Q2 |
2022-05-27 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
2022-05-25 | - | Årsstämma |
2022-05-18 | - | Kvartalsrapport 2022-Q1 |
2022-02-23 | - | Bokslutskommuniké 2021 |
2021-11-18 | - | Kvartalsrapport 2021-Q3 |
2021-08-25 | - | Kvartalsrapport 2021-Q2 |
2021-05-27 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
2021-05-26 | - | Årsstämma |
2021-05-05 | - | Kvartalsrapport 2021-Q1 |
2021-02-23 | - | Bokslutskommuniké 2020 |
2020-11-18 | - | Kvartalsrapport 2020-Q3 |
2020-08-26 | - | Kvartalsrapport 2020-Q2 |
2020-07-01 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
2020-06-30 | - | Årsstämma |
2020-05-05 | - | Kvartalsrapport 2020-Q1 |
2020-02-14 | - | Bokslutskommuniké 2019 |
2019-11-14 | - | Kvartalsrapport 2019-Q3 |
2019-08-20 | - | Kvartalsrapport 2019-Q2 |
2019-05-22 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
2019-05-21 | - | Årsstämma |
2019-05-09 | - | Kvartalsrapport 2019-Q1 |
2019-02-20 | - | Bokslutskommuniké 2018 |
2018-11-15 | - | Kvartalsrapport 2018-Q3 |
2018-08-23 | - | Kvartalsrapport 2018-Q2 |
2018-05-31 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
2018-05-29 | - | Årsstämma |
2018-05-09 | - | Kvartalsrapport 2018-Q1 |
2018-02-15 | - | Bokslutskommuniké 2017 |
2017-11-22 | - | Kvartalsrapport 2017-Q3 |
2017-08-24 | - | Kvartalsrapport 2017-Q2 |
2017-05-24 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
2017-05-23 | - | Årsstämma |
2017-05-19 | - | Kvartalsrapport 2017-Q1 |
2017-02-17 | - | Bokslutskommuniké 2016 |
2016-11-18 | - | Kvartalsrapport 2016-Q3 |
2016-08-25 | - | Kvartalsrapport 2016-Q2 |
2016-05-18 | - | X-dag ordinarie utdelning RAY B 0.25 SEK |
2016-05-17 | - | Årsstämma |
2016-05-12 | - | Kvartalsrapport 2016-Q1 |
2016-02-18 | - | Bokslutskommuniké 2015 |
2015-11-25 | - | Kvartalsrapport 2015-Q3 |
2015-08-28 | - | Kvartalsrapport 2015-Q2 |
2015-05-29 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
2015-05-28 | - | Årsstämma |
2015-05-08 | - | Kvartalsrapport 2015-Q1 |
2015-02-12 | - | Bokslutskommuniké 2014 |
2014-11-27 | - | Kvartalsrapport 2014-Q3 |
2014-08-27 | - | Kvartalsrapport 2014-Q2 |
2014-05-28 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
2014-05-27 | - | Årsstämma |
2014-05-16 | - | Kvartalsrapport 2014-Q1 |
2014-02-13 | - | Bokslutskommuniké 2013 |
2013-11-27 | - | Kvartalsrapport 2013-Q3 |
2013-08-28 | - | Kvartalsrapport 2013-Q2 |
2013-05-23 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
2013-05-22 | - | Årsstämma |
2013-05-16 | - | Kvartalsrapport 2013-Q1 |
2013-02-14 | - | Bokslutskommuniké 2012 |
2012-11-16 | - | Kvartalsrapport 2012-Q3 |
2012-08-28 | - | Kvartalsrapport 2012-Q2 |
2012-05-31 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
2012-05-30 | - | Årsstämma |
2012-05-23 | - | Kvartalsrapport 2012-Q1 |
2012-02-16 | - | Bokslutskommuniké 2011 |
2011-11-24 | - | Kvartalsrapport 2011-Q3 |
2011-05-26 | - | X-dag ordinarie utdelning RAY B 0.50 SEK |
2011-05-25 | - | Årsstämma |
2011-05-04 | - | Kvartalsrapport 2011-Q1 |
2011-02-18 | - | Bokslutskommuniké 2010 |
2010-11-12 | - | Kvartalsrapport 2010-Q3 |
2010-08-27 | - | Kvartalsrapport 2010-Q2 |
2010-05-26 | - | X-dag ordinarie utdelning RAY B 0.50 SEK |
2010-05-25 | - | Årsstämma |
2010-05-11 | - | Kvartalsrapport 2010-Q1 |
2009-11-20 | - | Kvartalsrapport 2009-Q3 |
2009-08-27 | - | Kvartalsrapport 2009-Q2 |
2009-05-27 | - | X-dag ordinarie utdelning RAY B 0.00 SEK |
2009-05-26 | - | Årsstämma |
2009-05-15 | - | Kvartalsrapport 2009-Q1 |
2008-06-25 | - | Split RAY B 1:3 |
2003-06-10 | - | Split RAY B 20:1 |
Beskrivning
Land | Sverige |
---|---|
Lista | Mid Cap Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
RaySearch Laboratories AB (publ) announces that Ion Beam Applications S.A. (IBA), market leader in proton therapy, has placed an order for RayStation®* treatment planning system and the oncology information system RayCare®* for installation at CRO National Cancer Institute (C.R.O.) in Aviano, Italy. RaySearch partnered with IBA for the public tender, with IBA serving as the main system integrator.
The order includes implementation of both RayStation and RayCare at C.R.O. Aviano. The combination of RayStation and RayCare provides an integrated and unified solution throughout the complete workflow, when combined with an IBA proton therapy machine.
IBA signed the contract with C.R.O. Aviano in November 2021 following a comprehensive vendor selection process. RaySearch partnered with IBA for the public tender and the center has now decided to select RayStation and RayCare. RayStation includes a complete set of licencs for pencil beam scanning, including automatic proton therapy planning using machine learning techniques. RayCare includes licences to cover the workflow management and the treatment delivery for all patients treated with proton therapy.
C.R.O. Aviano is expected to start treating patients by the end of 2024.
Johan Löf, founder and CEO, RaySearch, says: "We are very pleased to provide C.R.O. Aviano with RayStation and RayCare. The adoption of both RaySearch solutions at C.R.O. Aviano will enhance implementation efficiency as well as the possibility to optimize clinical excellence of proton therapy at this center. For RaySearch, this agreement further strengthens our prominent role in both treatment planning and oncology information systems for proton therapy centers in Europe."
The total order value is EUR 1.7 million (approximately SEK 19 million). A service contract is not included but is expected to be added at a later stage.
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
johan.lof@raysearchlabs.com